These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28542831)

  • 1. Machine learning reveals a non-canonical mode of peptide binding to MHC class II molecules.
    Andreatta M; Jurtz VI; Kaever T; Sette A; Peters B; Nielsen M
    Immunology; 2017 Oct; 152(2):255-264. PubMed ID: 28542831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recognition of core and flanking amino acids of MHC class II-bound peptides by the T cell receptor.
    Sant'Angelo DB; Robinson E; Janeway CA; Denzin LK
    Eur J Immunol; 2002 Sep; 32(9):2510-20. PubMed ID: 12207335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accurate pan-specific prediction of peptide-MHC class II binding affinity with improved binding core identification.
    Andreatta M; Karosiene E; Rasmussen M; Stryhn A; Buus S; Nielsen M
    Immunogenetics; 2015 Nov; 67(11-12):641-50. PubMed ID: 26416257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prediction of MHC class II binding affinity using SMM-align, a novel stabilization matrix alignment method.
    Nielsen M; Lundegaard C; Lund O
    BMC Bioinformatics; 2007 Jul; 8():238. PubMed ID: 17608956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NN-align. An artificial neural network-based alignment algorithm for MHC class II peptide binding prediction.
    Nielsen M; Lund O
    BMC Bioinformatics; 2009 Sep; 10():296. PubMed ID: 19765293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of structural requirements for interaction of the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells.
    Leighton J; Sette A; Sidney J; Appella E; Ehrhardt C; Fuchs S; Adorini L
    J Immunol; 1991 Jul; 147(1):198-204. PubMed ID: 1711074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of tripeptides in MHC binding peptides.
    Anishettt S; Pennathur G
    Protein Pept Lett; 2007; 14(6):552-6. PubMed ID: 17627595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural properties of MHC class II ligands, implications for the prediction of MHC class II epitopes.
    Jørgensen KW; Buus S; Nielsen M
    PLoS One; 2010 Dec; 5(12):e15877. PubMed ID: 21209859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico prediction of peptide-MHC binding affinity using SVRMHC.
    Liu W; Wan J; Meng X; Flower DR; Li T
    Methods Mol Biol; 2007; 409():283-91. PubMed ID: 18450008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules.
    Appella E; Padlan EA; Hunt DF
    EXS; 1995; 73():105-19. PubMed ID: 7579970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Energy landscapes of peptide-MHC binding.
    Collesano L; Łuksza M; Lässig M
    PLoS Comput Biol; 2024 Sep; 20(9):e1012380. PubMed ID: 39226310
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarity between segments in protein conformational epitopes and MHC II peptides.
    Li G; Wu D; Wang S; Sun J; Xu D; Cao Z
    Int J Comput Biol Drug Des; 2013; 6(1-2):107-18. PubMed ID: 23428477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction and analysis of promiscuous T cell-epitopes derived from the vaccine candidate antigens of Leishmania donovani binding to MHC class-II alleles using in silico approach.
    Kashyap M; Jaiswal V; Farooq U
    Infect Genet Evol; 2017 Sep; 53():107-115. PubMed ID: 28549876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A practical guide to structure-based prediction of MHC-binding peptides.
    Ranganathan S; Tong JC
    Methods Mol Biol; 2007; 409():301-8. PubMed ID: 18450010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting Class II MHC-Peptide binding: a kernel based approach using similarity scores.
    Salomon J; Flower DR
    BMC Bioinformatics; 2006 Nov; 7():501. PubMed ID: 17105666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MHC2MIL: a novel multiple instance learning based method for MHC-II peptide binding prediction by considering peptide flanking region and residue positions.
    Xu Y; Luo C; Qian M; Huang X; Zhu S
    BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S9. PubMed ID: 25521198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved peptide-MHC class II interaction prediction through integration of eluted ligand and peptide affinity data.
    Garde C; Ramarathinam SH; Jappe EC; Nielsen M; Kringelum JV; Trolle T; Purcell AW
    Immunogenetics; 2019 Jul; 71(7):445-454. PubMed ID: 31183519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unbiased Characterization of Peptide-HLA Class II Interactions Based on Large-Scale Peptide Microarrays; Assessment of the Impact on HLA Class II Ligand and Epitope Prediction.
    Wendorff M; Garcia Alvarez HM; Østerbye T; ElAbd H; Rosati E; Degenhardt F; Buus S; Franke A; Nielsen M
    Front Immunol; 2020; 11():1705. PubMed ID: 32903714
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Static energy analysis of MHC class I and class II peptide-binding affinity.
    Davies MN; Flower DR
    Methods Mol Biol; 2007; 409():309-20. PubMed ID: 18450011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of the same HIV peptide functionally binding to both a class I and a class II MHC molecule.
    Takeshita T; Takahashi H; Kozlowski S; Ahlers JD; Pendleton CD; Moore RL; Nakagawa Y; Yokomuro K; Fox BS; Margulies DH
    J Immunol; 1995 Feb; 154(4):1973-86. PubMed ID: 7530749
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.